Janney Montgomery Scott LLC Co Diagnostics, Inc. Transaction History

Janney Montgomery Scott LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$2.87 - $7.01 $9,471 - $23,133	-3,300 Reduced 19.41%	13,700 $44,000
Q2 2022 Aug 03, 2022	SELL	$3.76 - $6.29 $67,943 - $113,660	-18,070 Reduced 51.53%	17,000 $87,000
Q1 2022 May 04, 2022	SELL	$5.03 - $9.61 $14,587 - $27,869	-2,900 Reduced 7.64%	35,070 $217,000
Q4 2021 Jan 27, 2022	BUY	$8.12 - $10.37 $143,318 - $183,030	17,650 Added 86.86%	37,970 $339,000
Q3 2021 Oct 29, 2021	BUY	$7.48 - $11.38 $151,993 - $231,241	20,320 New	20,320 $198,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $27.7M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.